# RANI (Rani Therapeutics Holdings, Inc.) - SEC EDGAR Financial Statements

> Rani Therapeutics Holdings, Inc. reported $6.58M in revenue and a net loss of $32.46M for the trailing twelve months ended September 30, 2026 (up 58.9% year over year), with a -530.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/RANI
- Markdown: https://convexityos.com/fundamentals/RANI.md
- SEC CIK: 0001856725
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001856725&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $6.58M | +58.9% YoY |
| Operating Income | TTM | -$34.92M | -530.5% margin |
| Net Income | TTM | -$32.46M | -493.0% net margin |
| Diluted EPS | TTM | -$0.16 | Split-adjusted |
| Free Cash Flow | TTM | -$23.22M | -352.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $3.62M | Total debt: $3.15M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.63M | $1.03M | $0 | $0 | $2.72M | $462K |
| Research & Development | $20.20M | $26.68M | $39.62M | $36.61M | $26.48M | $12.04M |
| Total Operating Expenses | $39.94M | $54.34M | $66.10M | $63.45M | $54.32M | -$17.01M |
| **Operating Income** | -$38.31M | -$53.31M | -$66.10M | -$63.45M | -$51.60M | -$16.54M |
| **EBITDA** | -$37.41M | -$52.29M | -$65.28M | -$62.90M | -$51.10M | -$15.96M |
| Interest Income | -- | -- | -- | -- | $89K | $63K |
| Interest Expense | $2.89M | $5.03M | $5.08M | $1.07M | $466K | $124K |
| Income Before Tax | -- | -- | -$67.88M | -$63.27M | -$53.05M | -$16.67M |
| Income Tax Expense | $0 | $0 | $0 | $70K | $41K | $35K |
| **Net Income** | -$29.67M | -$30.02M | -$33.97M | -$30.59M | -$8.33M | -$16.70M |
| Basic EPS | -$0.45 | -$1.05 | -$1.33 | -$1.28 | -$0.43 | -- |
| **Diluted EPS** | -$0.45 | -$1.05 | -$1.33 | -$1.28 | -$0.43 | -- |
| Basic Shares Outstanding | 66.1K | 28.5K | 25.5K | 23.8K | 19.5K | -- |
| Diluted Shares Outstanding | 66.1K | 28.5K | 25.5K | 23.8K | 19.5K | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.71M | $1.71M | $1.71M | $1.46M | $0 | $0 | $172K | $1.03M |
| Research & Development | $6.02M | $5.02M | $5.16M | $4.91M | $3.22M | $5.50M | $6.57M | $6.81M |
| Total Operating Expenses | $10.93M | $10.54M | $10.05M | $10.00M | $7.26M | $10.51M | $12.19M | $15.99M |
| **Operating Income** | -$9.22M | -$8.83M | -$8.34M | -$8.54M | -$7.26M | -$10.51M | -$12.01M | -$14.96M |
| **EBITDA** | -$9.10M | -$8.68M | -$8.18M | -$8.35M | -$7.03M | -$10.27M | -$11.76M | -$14.69M |
| Interest Expense | $43K | $8.0K | $88K | $347K | $725K | $877K | $943K | $1.12M |
| **Net Income** | -$7.73M | -$7.39M | -$7.03M | -$10.30M | -$5.41M | -$6.69M | -$7.26M | -$8.95M |
| Basic EPS | -$0.04 | -$0.04 | -$0.04 | -- | -$0.12 | -$0.18 | -$0.22 | -- |
| **Diluted EPS** | -$0.04 | -$0.04 | -$0.04 | -- | -$0.12 | -$0.18 | -$0.22 | -- |
| Basic Shares Outstanding | 199.0M | 187.2M | 180.0M | -- | 46.4M | 36.5M | 33.4M | -- |
| Diluted Shares Outstanding | 199.0M | 187.2M | 180.0M | -- | 46.4M | 36.5M | 33.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $18.62M | $3.76M | $5.86M | $27.01M | $117.5M | $73.06M |
| Short-Term Investments | -- | -- | -- | $98.50M | -- | -- |
| **Cash & Short-Term Investments** | $18.62M | $3.76M | $5.86M | $125.5M | $117.5M | $73.06M |
| Accounts Receivable, Net | $2.04M | $0 | -- | -- | -- | -- |
| **Total Current Assets** | $53.32M | $29.74M | $50.85M | $100.9M | $119.6M | $74.94M |
| Property, Plant & Equipment, Net | $736K | $1.55M | $6.11M | $6.04M | $4.61M | $4.47M |
| Other Non-Current Assets | $246K | $246K | $246K | $0 | -- | -- |
| **Total Non-Current Assets** | $5.30M | $6.89M | $7.07M | $7.10M | $4.61M | $4.47M |
| **Total Assets** | $58.62M | $36.63M | $57.92M | $108.0M | $124.2M | $79.42M |
| Accounts Payable | $309K | $1.36M | $648K | $1.46M | $1.08M | $537K |
| Short-Term Debt | $0 | $15.00M | $4.90M | $0 | -- | $1.36M |
| Deferred Revenue (Current) | $6.83M | $0 | -- | -- | -- | $2.72M |
| **Total Current Liabilities** | $12.67M | $19.89M | $7.99M | $4.82M | $2.64M | $5.31M |
| Long-Term Debt | $0 | $9.61M | $24.48M | $29.15M | $0 | $2.41M |
| Deferred Revenue (Non-Current) | $1.71M | $0 | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $4.44M | $13.25M | $24.48M | $29.21M | $0 | $2.73M |
| **Total Liabilities** | $17.11M | $33.14M | $32.47M | $34.02M | $2.64M | $8.04M |
| **Total Debt (incl. Leases)** | $4.32M | $29.71M | $30.10M | $30.21M | $0 | $3.77M |
| Common Stock | -- | -- | -- | -- | -- | $0 |
| Retained Earnings | -$132.6M | -$102.9M | -$72.89M | -$38.92M | -$8.33M | -$114.0M |
| Accumulated Other Comp. Income | $1.0K | $5.0K | -$12K | -$73K | $0 | -- |
| **Total Stockholders' Equity** | $33.01M | $1.99M | $12.87M | $36.85M | $47.41M | -$113.3M |
| Total Equity | $41.51M | $3.49M | $25.44M | $74.00M | $121.6M | -$113.3M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.62M | $4.87M | $9.64M | $18.62M | $4.14M | $10.22M | $10.11M | $3.76M |
| **Cash & Short-Term Investments** | $3.62M | $4.87M | $9.64M | $18.62M | $4.14M | $10.22M | $10.11M | $3.76M |
| Accounts Receivable, Net | $1.96M | $2.04M | $2.04M | $2.04M | -- | -- | $600K | $0 |
| **Total Current Assets** | $48.48M | $56.52M | $47.09M | $53.32M | $4.96M | $11.07M | $17.78M | $29.74M |
| Property, Plant & Equipment, Net | $659K | $525K | $601K | $736K | $922K | $1.14M | $1.35M | $1.55M |
| Other Non-Current Assets | $246K | $246K | $246K | $246K | $245K | $293K | $246K | $246K |
| **Total Non-Current Assets** | $4.05M | $4.32M | $4.79M | $5.30M | $5.18M | $5.83M | $6.34M | $6.89M |
| **Total Assets** | $52.53M | $60.84M | $51.88M | $58.62M | $10.14M | $16.90M | $24.12M | $36.63M |
| Accounts Payable | $454K | $1.05M | $858K | $309K | $2.47M | $1.80M | $1.52M | $1.36M |
| Short-Term Debt | -- | -- | -- | $0 | $13.54M | $15.00M | $15.00M | $15.00M |
| Deferred Revenue (Current) | $3.42M | $5.12M | $6.83M | $6.83M | -- | -- | -- | $0 |
| **Total Current Liabilities** | $9.22M | $10.64M | $13.86M | $12.67M | $19.14M | $20.62M | $20.13M | $19.89M |
| Long-Term Debt | -- | -- | -- | $0 | $0 | $2.23M | $5.92M | $9.61M |
| Deferred Revenue (Non-Current) | $0 | $0 | $0 | $1.71M | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $1.95M | $2.22M | $2.48M | $4.44M | $2.97M | $5.43M | $9.34M | $13.25M |
| **Total Liabilities** | $11.18M | $12.86M | $16.34M | $17.11M | $22.11M | $26.05M | $29.47M | $33.14M |
| **Total Debt (incl. Leases)** | $3.15M | $3.55M | $3.94M | $4.32M | $17.55M | $21.62M | $25.67M | $29.71M |
| Retained Earnings | -$154.7M | -$147.0M | -$139.6M | -$132.6M | -$122.3M | -$116.9M | -$110.2M | -$102.9M |
| Accumulated Other Comp. Income | -$57K | -$30K | -$8.0K | $1.0K | $3.0K | $3.0K | $2.0K | $5.0K |
| **Total Stockholders' Equity** | $33.97M | $39.23M | $28.41M | $33.01M | -$7.86M | -$5.58M | -$3.06M | $1.99M |
| Total Equity | $41.35M | $47.98M | $35.54M | $41.51M | -$11.97M | -$9.15M | -$5.35M | $3.49M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$40.95M | -$56.58M | -$67.88M | -$63.34M | -$53.09M | -$16.70M |
| Depreciation & Amortization | $900K | $1.03M | $822K | $548K | $497K | $589K |
| Stock-Based Compensation | $11.80M | $16.03M | $19.01M | $15.78M | $22.59M | $0 |
| Change in Receivables | -$2.04M | $0 | -- | -- | -- | -- |
| Change in Payables | -$1.05M | $711K | -$595K | $163K | $543K | $933K |
| **Operating Cash Flow** | -$18.71M | -$35.50M | -$51.24M | -$46.52M | -$32.24M | -$14.96M |
| Capital Expenditure | -$88K | -$268K | -$1.23M | -$1.62M | -$506K | -$1.20M |
| **Free Cash Flow** | -$18.80M | -$35.76M | -$52.47M | -$48.13M | -$32.75M | -$16.16M |
| Purchases of Investments | -$33.69M | -$57.47M | -$73.26M | -$73.82M | $0 | -- |
| **Investing Cash Flow** | -$7.03M | $19.81M | $29.86M | -$72.44M | -$506K | -$1.20M |
| Common Stock Issued | -- | -- | -- | -- | $71.10M | -- |
| **Financing Cash Flow** | $40.30M | $13.59M | $233K | $29.00M | $77.15M | $72.68M |
| **Net Change in Cash** | $14.56M | -$2.10M | -$21.14M | -$89.95M | $44.40M | $56.52M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.81M | -$8.42M | -$8.02M | -$9.07M | -$7.91M | -$11.22M | -$12.74M | -$15.72M |
| Depreciation & Amortization | $123K | $152K | $161K | $186K | $223K | $240K | $251K | $266K |
| Stock-Based Compensation | $2.21M | $2.42M | $2.08M | $2.24M | $2.34M | $3.29M | $3.92M | $3.99M |
| Change in Receivables | -- | $0 | $0 | -$2.47M | $0 | $1.03M | -$600K | $0 |
| Change in Payables | -$263K | -$204K | $549K | -$2.16M | $669K | $278K | $161K | -$207K |
| **Operating Cash Flow** | -$7.76M | -$9.03M | -$6.50M | $294K | -$5.06M | -$5.80M | -$8.15M | -$8.65M |
| Capital Expenditure | -$183K | -$32K | -$15K | $0 | $0 | -$37K | -$51K | -$31K |
| **Free Cash Flow** | -$7.94M | -$9.06M | -$6.51M | $294K | -$5.06M | -$5.83M | -$8.20M | -$8.69M |
| Purchases of Investments | -$15.05M | -$34.48M | -$23.43M | -$30.97M | $0 | $0 | -$2.72M | -$17.75M |
| **Investing Cash Flow** | $6.86M | -$14.56M | -$2.45M | -$30.97M | $0 | $5.71M | $18.23M | $2.52M |
| **Financing Cash Flow** | -$347K | $18.81M | -$27K | $44.85M | -$1.01M | $188K | -$3.73M | $5.62M |
| **Net Change in Cash** | -$1.25M | -$4.78M | -$8.97M | $14.17M | -$6.07M | $105K | $6.35M | -$515K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -2346.0% | -5186.2% | -- | -- | -1899.1% | -3581.0% |
| **Net Profit Margin** | -1817.1% | -2920.0% | -- | -- | -306.6% | -3615.4% |
| Return on Equity (ROE) | -89.9% | -1506.9% | -264.0% | -83.0% | -17.6% | -- |
| Return on Assets (ROA) | -50.6% | -81.9% | -58.7% | -28.3% | -6.7% | -21.0% |
| Current Ratio | 4.21x | 1.50x | 6.36x | 20.96x | 45.30x | 14.12x |
| Quick Ratio | 1.63x | 0.19x | 0.73x | 26.07x | 44.49x | 13.76x |
| Debt to Equity | 0.13x | 14.91x | 2.34x | 0.82x | 0.00x | -- |
| **Revenue Growth (YoY)** | +58.9% | -- | -- | -100.0% | +488.1% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -530.5% | -675.8% | -1093.0% | -2346.0% | -3727.8% | -4106.2% | -4274.5% | -5186.3% |
| **Net Profit Margin** | -493.0% | -618.0% | -929.1% | -1817.1% | -2359.6% | -2473.8% | -2483.2% | -2920.0% |
| Return on Equity (ROE) | -95.5% | -76.8% | -103.7% | -89.9% | -- | -- | -- | -1506.9% |
| Return on Assets (ROA) | -61.8% | -49.5% | -56.8% | -50.6% | -279.3% | -175.7% | -123.5% | -81.9% |
| Current Ratio | 5.26x | 5.31x | 3.40x | 4.21x | 0.26x | 0.54x | 0.88x | 1.50x |
| Quick Ratio | 0.61x | 0.65x | 0.84x | 1.63x | 0.22x | 0.50x | 0.53x | 0.19x |
| Debt to Equity | 0.09x | 0.09x | 0.14x | 0.13x | -- | -- | -- | 14.91x |
| **Revenue Growth (YoY)** | -- | -- | +893.0% | +42.1% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
